skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial

Journal Article · · Cardiovascular and Interventional Radiology
; ; ;  [1]; ;  [2]; ; ;  [3];  [4];  [3]
  1. University of Magdeburg, Department of Radiology (Germany)
  2. University of Magdeburg, Institute of Pathology (Germany)
  3. Otto von Guericke University of Magdeburg, Department of Urology, University Hospital (Germany)
  4. Sana Klinikum Offenbach Am Main, Institute of Pathology (Germany)

IntroductionIt is postulated that focal IRE affords complete ablation of soft-tissue tumours while protecting the healthy peritumoral tissue. Therefore, IRE may be an interesting option for minimally invasive, kidney-tissue-sparing, non-thermal ablation of renal tumours.AimWith this current pilot study (“IRENE trial”), we present the first detailed histopathological data of IRE of human RCC followed by delayed tumour resection. The aim of this interim analysis of the first three patients was to investigate the ablation efficiency of percutaneous image-guided focal IRE in RCC, to assess whether a complete ablation of T1a RCC and tissue preservation with the NanoKnife system is possible and to decide whether the ablation parameters need to be altered.MethodsFollowing resection 4 weeks after percutaneous IRE, the success of ablation and detailed histopathological description were used to check the ablation parameters.ResultsThe IRE led to a high degree of damage to the renal tumours (1 central, 2 peripheral; size range 15–17 mm). The postulated homogeneous, isomorphic damage was only partly confirmed. We found a zonal structuring of the ablation zone, negative margins and, enclosed within the ablation zone, very small tumour residues of unclear malignancy.ConclusionAccording to these initial, preliminary study results of the first three renal cases, a new zonal distribution of IRE damage was described and the curative intended, renal saving focal ablation of localised RCC below <3 cm by percutaneous IRE by the NanoKnife system appears to be possible, but needs further, systematic evaluation for this treatment method and treatment protocol.

OSTI ID:
22469599
Journal Information:
Cardiovascular and Interventional Radiology, Vol. 39, Issue 2; Conference: BSIR 2015: Britisch Society of Interventional Radiology 2015 annual meeting, Glasgow, Scotland (United Kingdom), 4-6 Nov 2015; Other Information: Copyright (c) 2016 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); http://www.springer-ny.com; Country of input: International Atomic Energy Agency (IAEA); ISSN 0174-1551
Country of Publication:
United States
Language:
English

Similar Records

Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study
Journal Article · Tue Feb 15 00:00:00 EST 2011 · Cardiovascular and Interventional Radiology · OSTI ID:22469599

Short- and Mid-term Effects of Irreversible Electroporation on Normal Renal Tissue: An Animal Model
Journal Article · Mon Apr 15 00:00:00 EDT 2013 · Cardiovascular and Interventional Radiology · OSTI ID:22469599

Prospective Analysis of the Safety and Efficacy of Percutaneous Cryoablation for pT1NxMx Biopsy-Proven Renal Cell Carcinoma
Journal Article · Wed Jun 15 00:00:00 EDT 2011 · Cardiovascular and Interventional Radiology · OSTI ID:22469599